IL6 and tuberculosis: In the 3 organs studied, Dox led to a weaker downregulation of many of these terms, as shown by GSEA (Supplemental Figure 7B), suggesting that it does not lower systemic IFV-driven inflammation as efficiently as 9-TB, which is also consistent with its more moderate impact on IL-6 plasma levels (Figure 4D).